The basal ganglia of rhesus and squirrel monkeys were examined using immunohistochemical techniques with antibodies against the neurotensin-related hexapeptides LysS-Asn9-Neurotensin(8 -13) (LANT6) and Neuromedin N. A high percentage of neurons in both segments of globus paUidus and many large neurons of the striatum were found to label for LANT6, but not Neuromedin N. Previous studies have shown that LANT6 or a LANT6-1ike substance is present in many pallidal neurons in a wide range of vertebrate species. The current results indicate that a LANT6-1ike substance that is distinct from Neuromedin N is also present in many pallidal neurons in primates. This raises the possibility that this substance may be involved in neurotransmission between the pallidum and its projection targets.
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The neurotensin-related hexapeptide Lys8-Asn 9-Neurotensin(8-13) (LANT6) 5'6'7 has been found in the vast majority of pallidal neurons in the avian basal ganglia 28'29. Many of these neurons have been shown to give rise to a LANT6-containing projection to tegmental dopaminergic neurons. Biochemical and immunohistochemical studies have also revealed the presence of a LANT6-1ike peptide in many pallidal neurons of the basal forebrain in turtles and hamsters 28'29. Although the substance in pallidal neurons in turtles and hamsters may differ from avian LANT6 as sequenced by Carraway and Ferris4, the LANT6-1ike peptide found in pallidal neurons in these animal groups is not neuromedin N, a neurotensin-related hexapeptide isolated originally from porcine spinal cord and differing from LANT6 by the substitution of isoleucine for asparagine as the second amino acid 19, or neurotensin itself. Immunohistochemical studies have shown that a LANT6-1ike peptide is also present in pallidal neurons in other reptiles (crocodilians), as well as in bony fish (lungfish) and cartilaginous fish (sharks) 28-3°. Since pallidal neurons are thought to use y-aminobutyric acid (GABA) as their neurotransmitter 17, the above resuits suggest that LANT6 and GABA may co-occur in pallidal neurons. Double-label studies specifically examining this issue in pigeons have shown that GABA and LANT6 do co-occur in many pallidal neurons of the avian basal telencephalon 26. Thus, the studies noted above raise the possibility that pallidal neurons in a wide variety of vertebrate species may use GABA, as well as LANT6 or a LANT6-1ike substance, to influence neurons in their projection targets. Although no data are available on the influence of LANT6 on neurons in the target areas of pallidal neurons, several lines of evidence suggest that LANT6 may influence these target neurons. First, LANT6 is highly concentrated in synaptosomal fractions of avian brain, suggesting that it may be a neuroactive substance released by synaptic terminals 6. Second, LANT6 does appear to bind to neurotensin receptors, although with low affinity 9'16, and neurotensin receptors are rich in at least one target area of pallidal neurons, namely the dopaminergic neurons of the tegmentum 3'21,21,25. Finally, substances related in structure to LANT6 (such as Neuromedin N and sectioned. Sections through the basal ganglia were sectioned at 30-40/~m on a sliding microtome and processed according to the peroxidase-antiperoxidase (PAP) procedure as described previously 2s'29, using antisera against either neurotensin (purchased from the ImmunoNuclear Corporation), Neuromedin N (NMN) (provided by R.E. Carraway) or LANT6 (provided by R.E. Carraway). The specificity of these antisera for their target peptides has been confirmed in previous studies 6'28'29 and was also evaluated in the present studies. In brief, the anti-LANT6 antiserum is specific for the N-terminus of LANT6 and does not cross-react with either neurotensin or NMN. While neither the anti-neurotensin antiserum nor the anti-NMN antiserum cross-react with LANT6, they do cross-react slightly with one another's antigens. Using the anti-LANT6 antiserum, abundant heavily labeled neurons were found in both segments of the globus pallidus (Figs. 1,2) . Neuronal labeling was not observed in either segment of globus pallidus with either the anti-neurotensin antiserum or the anti-NMN antiserum. The perikarya of the LANT6+ neurons in globus pallidus were either ovoid or polygonal in shape, with the former ranging from 20 to 30 ktm in diameter and the latter from 20 to 30/~m in the short axis and 30-40/~m in the long axis. Pallidal neurons in adjacent sections stained with Cresyl violet were typically of a similar size and shape as the LANT6+ pallidal neurons. In rhesus monkey, the number of LANT6+ neurons in globus pallidus per unit area in immunohistochemically processed sections was compared to the number of neurons in globus pallidus per unit area in adjacent Nissl-stained sections. The results indicated that a greater percentage of the neurons in the lateral globus pallidus (approximately 75%) were labeled for LANT6 than in the medial globus pallidus (approximately 50%).
LANT6+ neurons were also observed in the stria° rum (Figs. 1,2) . These neurons were not labeled with either the anti-neurotensin antiserum or the anti-NMN antiserum. These LANT6÷ striatal neurons were also large (approximately 20/~m) and their perikarya were typically round or polygonal in shape. These striatal neurons made up only a small percentage of the total number of striatal neurons (less than 1%). In Nissl-stained sections, neurons of this size and shape were also observed to be rare and make up less than 1% of the total number of striatal neurons (the vast majority of which, as reported by others, are medium-sized) 7. Since the dendrites of these LANT6+ neurons were generally not well-labeled, the dendritic morphology of these neurons could not be well characterized. In the case of those perikarya where some dendritic labeling was observed, 3 or more thin dendrites were observed to extend from the cell body. The LANT6+ neurons were found throughout the striatum and, as shown in Fig. 1, they were not uniformly distributed in the striatum. To determine the relationship of the distribution of these neurons to the cholinesterase-poor patches of the striatum TM, the distribution of LANT6+ neurons was compared to the cholinesterase staining pattern (using the procedure of Mesulam and Van Hoesen TM) in adjacent sections. The results indicated that, although LANT6+ neurons are not uniformly distributed in the striatum, neither regions of high LANT6+ perikaryal density nor regions of low LANT6+ perikaryal density consistently correlated with either ACHE-poor or ACHE-rich zones. Thus, LANT6+ neurons are present in both patch and matrix compartments of the striatum. Finally, as in pigeons, turtles and hamsters 2s'29, LANT6+ neurons were also observed in the ventral pallidum and in the polymorph layer of the olfactory tubercle (Fig. 1) . Additional LANT6+ neurons were observed in the diagonal band of Broca/nucleus basalis portion of the telencephalon. As in the case of the striatum and globus pallidus, the LANT6+ neurons in these regions were large (20-30/~m).
The present results thus show that in primates, as in hamsters and a variety of non-mammalian species 28-3°, a LANT6-1ike substance is present in neurons of globus pallidus. Although the precise identity of the LANT6-1ike substance in paUidal neurons in monkeys is unknown, this substance clearly is distinct from NMN and neurotensin (which are related in structure to LANT6), since pallidal neurons were not labeled with antisera against these substances. These latter antisera did, however, label neurons and fibers in other brain regions, thus suggesting that their failure to label pallidal neurons reflects the absence of neurotensin and NMN from pallidal neurons. Thus, as also recently shown in another mammalian species (i.e. hamsters) 29, the present results show that the nervous system of monkeys contains neurotensin, NMN and a distinct LANT6-1ike peptide, and that it is the LANT6-1ike peptide that is present in pallidal neurons. Previous studies in birds have shown that LANT6 is present in GABAergic pallidal neurons 26. Pallidal neurons in mammals are also thought to use GABA as their transmitter. In the light of this and in the light of the large number of LANT6+ pallidal neurons observed in monkeys, it appears likely that GABAergic pallidal neurons in monkeys contain a LANT6-1ike peptide.
The present results show that LANT6+ neurons are also present in the striatum in monkeys. These neurons are large, presumably aspiny, neurons that make up fewer than 1% of the total number of striatal neurons. These neurons are present in both patch and matrix compartments. LANT6+ striatal neurons are also present in the basal ganglia of birds and reptiles, but have not been observed in hamsters 29. The failure to observe LANT6+ striatal neurons in hamsters is of uncertain significance. Possibly these neurons are absent in hamsters, or possibly the LANT6-like substance they putatively contain differs considerably from avian LANT6 and is only poorly detected by the present antiserum against LANT6. Regardless, the present results clearly show that LANT6+ striatal neurons are demonstrable in at least some mammalian species. The precise relationship of these neurons to previously identified types of striatal neurons in mammals is uncertain. Since all LANT6+ striatal neurons in birds also contain GABA 26, it is possible that the LANT6+ striatal neurons in monkeys correspond to a class of large neurons that also contain GABA, such as the class of large striatonigral projection neurons reported in the striatum of some mammals 2. The LANT6+ striatal neurons, however, also show morphological resemblances to cholinergic striatal neurons 24, and the possibility cannot be excluded that some of the LANT6+ striatal neurons contain acetylcholine. It is clear, however, that the LANT6+ striatal neurons differ in size and morphology from the neurotensincontaining striatal neurons recently described in cats by Sugimoto and Mizuno 31, which are medium-sized spiny neurons.
The precise functional significance of the presence of a LANT6-1ike peptide in pallidal neurons has not yet been determined. Existing data, however, raise the possibility that at least some pallidal neurons use LANT6 as a neurotransmitter in feedback regulation of the dopaminergic neurons projecting to the basal ganglia. First, in both birds and reptiles, many LANT6+ pallidal neurons have been shown to project to the tegmental dopaminergic cell groups 29. Similarly, in mammals, the olfactory tubercle, the ventral pallidum and the lateral globus pallidus project to the ventral tegmental area and substantia nigra, which are rich in dopaminergic neurons 11"12 ' 20,23,32 , and it appears likely that LANT6+ neurons are among those projecting to these tegmental sites. Secondly, LANT6 has some affinity for neurotensin receptors and neurotensin receptors are present on tegmental dopaminergic neurons 9A6'22'25. Finally, neurotensin and NMN (both of which are structurally related to LANT6) are known to activate dopaminergic neurons, thus suggesting that LANT6 may also be able to influence dopaminergic neurons 1'13-15'21'33.
LANT6+ neurons were also observed in the medial pallidum segment (which projects to the ventral anterior/ventral lateral nuclei and the centromedianum/parafascicular complex of the thalamus) 7's' 11,12,20,23. Thus, it seems possible that medial pallidal neurons also use a LANT6-1ike peptide to influence their thalamic target neurons. However, since in rhesus monkey, as in hamsters, LANT6+ neurons are more abundant in the lateral portion of the pallidum than in the medial, the LANT6-1ike peptide in pallidal neurons in mammals may play a greater role in neurotransmission in the target areas of the lateral pallidum (which also include the subthalamic nucleus) 7,8,12.20 , than in target areas of the medial pallidum. Further understanding of the role of LANT6 would be aided by clarification of the identity and distribution of the receptor sites to which LANT6 binds.
In summary, although much remains to be determined about the functional significance of the presence of LANT6 in pallidal neurons and of its apparent co-localization with GABA, it is clear that a LANT6-1ike peptide is present in pallidal neurons in vertebrate species as distantly related as sharks and primates. These results reinforce previous observations on the high degree of evolutionary conservatism in the neurotransmitter/neuropeptide-specific populations of neurons making up the basal ganglia 27. Further, in the light of the striking evolutionary conservatism in the presence of LANT6 (or related substances) in pallidal neurons, it seems likely
